MARZO 2021

Lun	Mar	Mié	Jue	Vie	Sáb	Dom
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Publicaciones AGES-CM

Título	Año	Autores	Revista

Working definitions, subjective and objective assessments and experimental paradigms in a study exploring social withdrawal in schizophrenia and Alzheimer's disease	2019	van der Wee, NJA.; Bilderbeck, AC.; Cabello, M.; Ayuso-Mateos, JL.; Saris, IMJ.; Giltay, EJ.; Penninx, BW.; Arango, C.; Post, A.; Porcelli, S.	Neuroscience and Biobehavioral Reviews

Transdiagnostic dimensions of psychopathology at first episode psychosis: findings from the multinational EU-GEI study	2019	Quattrone, D.; Di Forti, M.; Gayer-Anderson, C.; Ferraro, L.; Jongsma, HE.; Tripoli, G et al.	Psychological Medicine

The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study	2019	Di Forti M, Quattrone D, Freeman TP, Tripoli G, Gayer-Anderson C, Quigley H, Rodriguez V, Jongsma HE, Ferraro L, La Cascia C, La Barbera D, Tarricone I, Berardi D, Szöke A, Arango C, Tortelli A, Velthorst E, Bernardo M, Del-Ben CM, Menezes PR, Selten JP, Jones PB, Kirkbride JB, Rutten BP, de Haan L, Sham PC, van Os J, Lewis CM, Lynskey M, Morgan C, Murray RM; EU-GEI WP2 Group.	Lancet Psychiatry
Smoking does not impact social and non-social cognition in patients with first episode psychosis	2019	Sánchez-Gutiérrez, T.; García-Portilla, MP.; Parellada, M.; Bobes, J.; Calvo, A.; Moreno-Izco, L.; González-Pinto, A.; Lobo, A.; de la Serna, E.; Cabrera, B.; Torrent, C.; Roldán, L.; Sanjuan, J.; Ibáñez, Á.; Sánchez-Torres, AM.; Corripio, I.; Bernardo, M.; Cuesta, MJ; PEPs group.	Schizophrenia Research
Re-thinking treatment targets in child and adolescent psychiatry	2019	Moreno C, Zuddas A.	European Child and Adolescent Psychiatry

Psychosocial risk factors for suicidality in children and adolescents	2019	Carballo, JJ.; Llorente, C.; Kehrmann, L.; Flamarique, I.; Zuddas, A.; Purper-Ouakil, D.; Hoekstra, PJ.; Coghill, D.; Schulze, UME.; Dittmann, RW.; Buitelaar, JK.; Castro-Fornieles, J.; Lievesley, K.; Santosh, P.; Arango, C; STOP Consortium.	European Child and Adolescent Psychiatry
Oxidative Stress and Inflammation in First-Episode Psychosis: A Systematic Review and Meta-analysis	2019	Fraguas, D.; Díaz-Caneja, CM.; Ayora, M.; Hernández-Álvarez, F.; Rodríguez-Quiroga, A.; Recio, S.; Leza, JC.; Arango, C.	Schizophrenia Bulletin

Overview of the clinical implementation of a study exploring social withdrawal in patients with schizophrenia and Alzheimer's disease	2019	Bilderbeck, AC.; Penninx, BWJH.; Arango, C.; van der Wee, N.; Kahn, R.; Winter-van Rossum, I.; Hayen, A.; Kas, MJ.; Post, A.; Dawson, GR.	Neuroscience and Biobehavioral Reviews

Neutrophil Count Is Associated With Reduced Gray Matter and Enlarged Ventricles in First-Episode Psychosis	2019	Núñez, C.; Stephan-Otto, C.; Usall, J.; Bioque, M.; Lobo, A.; González-Pinto, A.; Pina-Camacho, L.; Vieta, E.; Castro-Fornieles, J.; Rodriguez-Jimenez, R.; Butjosa, A.; Janssen, J.; Cabrera, B.; Parellada, M.; Bernardo, M; PEPs group.	Schizophrenia Bulletin
Mobile App-Based Intervention for Adolescents with First-Episode Psychosis: Study Protocol for a Pilot Randomized Controlled Trial	2019	Barbeito, S.; Sánchez-Gutiérrez, T.; Mayoral, M.; Moreno, M.; Ríos-Aguilar, S.; Arango, C.; Calvo, A.	Frontiers in psychiatry
Long-acting injectable antipsychotics for the treatment of schizophrenia in Spain	2019	Arango, C.; Baeza, I.; Bernardo, M.; Cañas, F.; de Dios, C.; Díaz-Marsá, M.; García-Portilla, MP.; Gutiérrez-Rojas, L.; Olivares, JM.; Rico-Villademoros, F.; Rodríguez-Jiménez, R.; Sánchez-Morla, EM.; Segarra, R.; Crespo-Facorro, B.	Revista de Psiquiatría y Salud Mental
Evaluating attention-deficit/hyperactivity disorder using ecological momentary assessment: a systematic review	2019	Miguelez-Fernandez, C.; de Leon, SJ.; Baltasar-Tello, I.; Peñuelas-Calvo, I.; Barrigon, ML.; Capdevila, AS.; Delgado-Gómez, D.; Baca-García, E.; Carballo, JJ.	Attention Deficit and Hyperactivity Disorders
Differences in the regulation of inflammatory pathways in adolescent- and adult-onset first-episode psychosis	2019	Moreno C, Parellada M, MacDowell KS, García-Bueno B, Cabrera B, González-Pinto A, Saiz P, Lobo A, Rodriguez-Jimenez R, Berrocoso E, Bernardo M, Leza JC; From the FLAMM-PEPs study.	European Child and Adolescent Psychiatry
Cognitive reserve as an outcome predictor: first-episode affective versus non-affective psychosis	2019	Amoretti, S.; Cabrera, B.; Torrent, C.; Mezquida, G.; Lobo, A.; González-Pinto, A.; Parellada, M.; Corripio, I.; Vieta, E.; de la Serna, E.; Butjosa, A.; Contreras, F.; Sarró, S.; Penadés, R.; Sánchez-Torres, AM.; Cuesta, M.; Bernardo, M; PEPsGroup.	Acta Psychiatrica Scandinavica
Cognition and functionality in delusional disorder	2019	Díaz-Caneja, C.; Cervilla, JA.; Haro, JM.; Arango, C.; de Portugal, E.	European Psychiatry
Affective versus first-episode non-affective first-episode psychoses: A longitudinal study	2019	Torrent, C.; Reinares, M.; Martinez-Arán, A.; Cabrera, B.; Amoretti, S.; Corripio, I.; Contreras, F.; Sarró, S.; González-Pinto, A.; Lobo, A.; Cuesta, MJ.; Sánchez-Torres, A.; Bergé, D.; Castro-Fornieles, J.; Moreno, M.; Bernardo, M.; Vieta, E.; PEPS group.	Journal of Affective Disorders
Factors associated with poor functional outcome in bipolar disorder: sociodemographic, clinical, and neurocognitive variables	2019	Sánchez-Moreno, J.; Bonnin, CM.; González-Pinto, A.; Amann, BL.; Solé, B.; Balanzá-Martinez, V.; Arango, C.; Jiménez, E.; Tabarés-Seisdedos, R.; Garcia-Portilla, MP.; Ibáñez, A.; Crespo, JM.; Ayuso-Mateos, JL.; Martinez-Aran, A.; Torrent, C.; Vieta, E.; CIBERSAM Functional Remediation Group.	Acta Psychiatrica Scandinavica

Negative symptoms of schizophrenia: new developments and unanswered research questions	2019	Galderisi, S.; Mucci, A.; Buchanan, RW.; Arango, C.	Lancet Psychiatry

Preventive strategies for mental health	2019	Arango, C.; M. Díaz-Caneja, C.; McGorry, P.; Rapoport, J.; Sommer, I.; Vorstman, J.; McDaid, D.; Marín, O.; Serrano-Drozdowskyj, E.; Freedman, R.; Carpenter, W.	Lancet Psychiatry

The complex association between the antioxidant defense system and clinical status in early psychosis	2019	García, S.; Alberich, S.; Martínez-Cengotitabengoa, M.; Arango, C.; Castro-Fornieles, J.; Parellada, M.; Baeza, I.; Moreno, C.; Micó, JA.; Berrocoso, E.; Graell, M.; Otero, S.; Simal, T.; González-Pinto, A.	PLoS One
Evolution of metabolic risk factors over a two-year period in a cohort of first episodes of psychosis	2019	Bioque, M.; García-Portilla, MAP.; García-Rizo, C.; Cabrera, B.; Lobo, A.; González-Pinto, A.; Díaz-Caneja, CM.; Corripio, I.; Vieta, E.; Castro-Fornieles, J.; Bobes, J.; Gutiérrez-Fraile, M.; Rodriguez-Jimenez, R.; Mezquida, G.; Llerena, A.; Saiz-Ruiz, J.; Bernardo, M; PEPs GROUP.	Schizophrenia Research
Attenuated psychotic symptoms in children and adolescent offspring of patients with schizophrenia	2019	Noguera, A.; Castro-Fornieles, J.; Romero, S.; de la Serna, E.; Sugranyes, G.; Sánchez-Gistau, V.; Moreno, D.; Díaz-Caneja, CM.; Merchán-Naranjo, J.; Llorente, C.; Baeza, I.	Schizophrenia Research
Negative Symptoms in Early-Onset Psychosis and Their Association With Antipsychotic Treatment Failure	2019	Downs, J.; Dean, H.; Lechler, S.; Sears, N.; Patel, R.; Shetty, H.; Hotopf, M.; Ford, T.; Kyriakopoulos, M.; Diaz-Caneja, CM.; Arango, C.; MacCabe, JH.; Hayes, RD.; Pina-Camacho, L.	Schizophrenia Bulletin.
Predictors of Placebo Response in Pharmacological Clinical Trials of Negative Symptoms in Schizophrenia: A Meta-regression Analysis	2019	Fraguas, D.; Díaz-Caneja, CM.; Pina-Camacho, L.; Umbricht, D.; Arango C.	Schizophrenia Bulletin.

A quantitative approach to neuropsychiatry: the why and the how	2019	Kas, MJ.; Penninx, B.; Sommer, B.; Serretti, A.; Arango, C.; Marston H.	Neuroscience & Biobehavioral Reviews

		…
Use of Ecological Momentary Assessment (EMA) in Non-Suicidal Self-Injury (NSSI) A systematic review	2018	Rodríguez-Blanco, L.; Carballo, JJ.; Baca-García, E	Psychiatry Research

Understanding the pediatric psychiatric phenotype of 22q11. 2 deletion síndrome	2018	Fiksinski, AM.; Schneider, M.; Murphy, CM.; Armando, M.; Vicari, S.; Canyelles, JM.; Gothelf, D.; Eliez, S.; Breetvelt, EJ.; Arango, C.; Vorstman, JAS.	American Journal of Medical Genetics Part A

Towards understanding and acting on risk factors for developmental psychopathology	2018	Moreno, C.	European Child and Adolescent Psychiatry


The Strengths and Difficulties Questionnaire -Dysregulation Profile, Non-Suicidal Self-Injury Behaviors and the Mediating Role of Stressful Life Events	2018	Caro-Cañizares, I.; Díaz de Neira-Hernando, M.; Pfang, B.; Baca-Garcia, E.; Carballo, JJ.	Spanish Journal of Psychology

The need for paediatric registries to assess long-term brain effects of psychotropic medications: The case of bipolar disorder	2018	Vieta, E.; Arango, C.; Rush, AJ.	European Neuropsychopharmacology
The complex association between the antioxidant defense system and clinical status in early psychosis	2018	García, S.; Alberich, S.; Martínez-Cengotitabengoa, M.; Arango, C.; Castro-Fornieles, J.; Parellada, M.; Baeza, I.; Moreno, C.; Micó, JA.; Berrocoso, E.; Graell, M.; Otero, S.; Simal, T.; González-Pinto, A.	PLoS One
Temperament in child and adolescent offspring of patients with schizophrenia and bipolar disorder	2018	Díaz-Caneja, CM.; Morón-Nozaleda, MG.; Vicente-Moreno, RP.; Rodríguez-Toscano, E.; Pina-Camacho, L.; de la Serna, E.; Sugranyes, G.; Baeza, I.; Romero, S.; Sánchez-Gistau, V.; Castro-Fornieles, J.; Moreno, C.; Moreno, D.	European Child and Adolescent Psychiatry
Stress hormones and verbal memory in young people over the first 12 weeks of treatment for psychosis	2018	Allott, KA.; Yuen, HP.; Bartholomeusz, CF.; Rapado-Castro, M.; Phassouliotis, C.; Butselaar, F.; Wood, SJ.; Proffitt, TM.; Savage, G.; Phillips, LJ.; Bendall, S.; Markulev, C.; Reniers, RLEP.; Pantelis, C.; Baldwin, L.; McGorry, PD.; Garner, B.	Psychiatry Research
Screening for the ADHD Phenotype Using the Strengths and Difficulties Questionnaire in a Clinical Sample of Newly Referred Children and Adolescents	2018	Carballo, JJ.; Rodríguez-Blanco, L.; García-Nieto, R.; Baca-García, E.	Journal of Attention Disorders
Preventive strategies for mental health	2018	Arango, C.; M. Díaz-Caneja, C.; McGorry, P.; Rapoport, J.; Sommer, I.; Vorstman, J.; McDaid, D.; Marín, O.; Serrano-Drozdowskyj, E.; Freedman, R.; Carpenter, W.	Lancet Psychiatry
Platform for systems medicine research and diagnostic applications in psychotic disorders-The METSY project	2018	Frank, E.; Maier, D.; Pajula, J.; Suvitaival, T.; Borgan, F.; Butz-Ostendorf, M.; Fischer, A.; Hietala, J.; Howes, O.; Hyötyläinen, T.; Janssen, J.; Laurikainen, H.; Moreno, C.; Suvisaari, J.; Van Gils, M.; Orešič, M.	European Psychiatry
One-Year Prospective Study of Liver Function Tests in Children and Adolescents on Second-Generation Antipsychotic	2018	Baeza, I.; Serna, E.; Calvo-Escalona, R.; Merchán-Naranjo, J.; Rodríguez-Latorre, P.; Martínez-Cantarero, MC.; Andrés, P.; Alda, JA.; Muñoz-Samons, D.; Ilzarbe, D.; Arango, C.; Castro-Fornieles, J.	Journal of Child and Adolescent Psychopharmacology
Negative symptoms of schizophrenia: new developments and unanswered research questions	2018	Galderisi, S.; Mucci, A.; Buchanan, RW.; Arango, C.	Lancet Psychiatry
Momentary Assessment and Mood Disorders in Children and Adolescents: a Systematic Review	2018	Baltasar-Tello, I.; Miguélez-Fernández, C.; Peñuelas-Calvo, I.; Carballo, JJ.	Current Psychiatry Reports
Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis	2018	Ballesteros, A.; Sánchez-Torres, AM.; López-Ilundain, JM.; Cabrera, B.; Lobo, A.; González-Pinto, AM.; Díaz-Caneja, C.; Corripio, I.; Vieta, E.; de la Serna, E.; Bobes, J.; Usall, J.; Contreras, F.; Lorente-Omeñaca, R.; Mezquida, G.;	Psychological Medicine
Impact of NTRK2, DRD2 and ACE polymorphisms on prolactin levels in antipsychotic-treated patients with first-episode psychosis	2018	Gassó, P.; Mas, S.; Bioque, M.; Cabrera, B.; Lobo, A.; González-Pinto, A.; Díaz-Caneja, CM.; Corripio, I.; Vieta, E.; Castro-Fornieles, J.; Sarró, S.; Mané, A.; Sanjuan, J.; Llerena, A.; Lafuente, A.; Saiz-Ruiz, J.; Bernardo, M; PEPs Group.	Journal of Psychopharmacology
Factors associated with poor functional outcome in bipolar disorder sociodemographic, clinical, and neurocognitive variables	2018	Sánchez-Moreno, J.; Bonnin, CM.; González-Pinto, A.; Amann, BL.; Solé, B.; Balanzá-Martinez, V.; Arango, C.; Jiménez, E.; Tabarés-Seisdedos, R.; Garcia-Portilla, MP.; Ibáñez, A.; Crespo, JM.; Ayuso-Mateos, JL.; Martinez-Aran, A.; Torrent, C.; Vieta, E.; CIBERSAM Functional Remediation Group.	Acta Psychiatrica Scandinavica
Evolution of metabolic risk factors over a two-year period in a cohort of first episodes of psychosis	2018	Bioque, M.; García-Portilla, MAP.; García-Rizo, C.; Cabrera, B.; Lobo, A.; González-Pinto, A.; Díaz-Caneja, CM.; Corripio, I.; Vieta, E.; Castro-Fornieles, J.; Bobes, J.; Gutiérrez-Fraile, M.; Rodriguez-Jimenez, R.; Mezquida, G.; Llerena, A.; Saiz-Ruiz, J.; Bernardo, M; PEPs GROUP.	Schizophrenia Research

Cardiovascular Risk in Early Psychosis: Relationship with Inflammation and Clinical Features 6 Months after Diagnosis	2018	Barcones, MF.; MacDowell, KS.; García-Bueno, B.; Bioque, M.; Gutiérrez-Galve, L.; González-Pinto, A.; Parellada, MJ.; Bobes, J.; Bernardo, M.; Lobo, A.; Leza, JC.	International Journal of Neuropsychopharmacology

Attenuated psychotic symptoms in children and adolescent offspring of patients with schizophrenia	2018	Noguera, A.; Castro-Fornieles, J.; Romero, S.; de la Serna, E.; Sugranyes, G.; Sánchez-Gistau, V.; Moreno, D.; Díaz-Caneja, CM.; Merchán-Naranjo, J.; Llorente, C.; Baeza, I.	Schizophrenia Research

Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study	2018	Kahn, RS.; Winter van Rossum, I.; Leucht, S.; McGuire, P.; Lewis, SW.; Leboyer, M.; Arango, C.; Dazzan, P.; Drake, R.; Heres, S.; Díaz-Caneja, CM.; Rujescu, D.; Weiser, M.; Galderisi, S.; Glenthøj, B.; Eijkemans, MJC.; Fleischhacker, WW.; Kapur, S.; Sommer, IE; OPTiMiSE study group.	Lancet Psychiatry
Alpha7 acetylcholine receptor autoantibodies are rare in sera of patients diagnosed with schizophrenia or bipolar disorder	2018	Hoffmann, C.; Stevens, J.; Zong, S.; van Kruining, D.; Saxena, A.; Küçükali, Cİ.; Tüzün, E.; Yalçınkaya, N.; De Hert, M.; González-Vioque, E.; Arango, C.; Lindstrom, J.; De Baets, MH.; Rutten, BPF.; van Os, J.; Molenaar, P.; Losen, M.; Martinez-Martinez, P.	Plos One
Affective versus first-episode non-affective first-episode psychoses: A longitudinal study	2018	Torrent, C.; Reinares, M.; Martinez-Arán, A.; Cabrera, B.; Amoretti, S.; Corripio, I.; Contreras, F.; Sarró, S.; González-Pinto, A.; Lobo, A.; Cuesta, MJ.; Sánchez-Torres, A.; Bergé, D.; Castro-Fornieles, J.; Moreno, M.; Bernardo, M.; Vieta, E.; PEPS group.	Journal of Affective Disorders
Factors associated with poor functional outcome in bipolar disorder: sociodemographic, clinical, and neurocognitive variables	2018	Sánchez-Moreno, J.; Bonnin, CM.; González-Pinto, A.; Amann, BL.; Solé, B.; Balanzá-Martinez, V.; Arango, C.; Jiménez, E.; Tabarés-Seisdedos, R.; Garcia-Portilla, MP.; Ibáñez, A.; Crespo, JM.; Ayuso-Mateos, JL.; Martinez-Aran, A.; Torrent, C.; Vieta, E.; CIBERSAM Functional Remediation Group.	Acta Psychiatrica Scandinavica

Negative symptoms of schizophrenia: new developments and unanswered research questions	2018	Galderisi, S.; Mucci, A.; Buchanan, RW.; Arango, C.	Lancet Psychiatry

Preventive strategies for mental health	2018	Arango, C.; M. Díaz-Caneja, C.; McGorry, P.; Rapoport, J.; Sommer, I.; Vorstman, J.; McDaid, D.; Marín, O.; Serrano-Drozdowskyj, E.; Freedman, R.; Carpenter, W.	Lancet Psychiatry
The complex association between the antioxidant defense system and clinical status in early psychosis	2018	García, S.; Alberich, S.; Martínez-Cengotitabengoa, M.; Arango, C.; Castro-Fornieles, J.; Parellada, M.; Baeza, I.; Moreno, C.; Micó, JA.; Berrocoso, E.; Graell, M.; Otero, S.; Simal, T.; González-Pinto, A.	PLoS One
Evolution of metabolic risk factors over a two-year period in a cohort of first episodes of psychosis	2018	Bioque, M.; García-Portilla, MAP.; García-Rizo, C.; Cabrera, B.; Lobo, A.; González-Pinto, A.; Díaz-Caneja, CM.; Corripio, I.; Vieta, E.; Castro-Fornieles, J.; Bobes, J.; Gutiérrez-Fraile, M.; Rodriguez-Jimenez, R.; Mezquida, G.; Llerena, A.; Saiz-Ruiz, J.; Bernardo, M; PEPs GROUP.	Schizophrenia Research
Attenuated psychotic symptoms in children and adolescent offspring of patients with schizophrenia	2018	Noguera, A.; Castro-Fornieles, J.; Romero, S.; de la Serna, E.; Sugranyes, G.; Sánchez-Gistau, V.; Moreno, D.; Díaz-Caneja, CM.; Merchán-Naranjo, J.; Llorente, C.; Baeza, I.	Schizophrenia Research

Negative Symptoms in Early-Onset Psychosis and Their Association With Antipsychotic Treatment Failure	2018	Downs, J.; Dean, H.; Lechler, S.; Sears, N.; Patel, R.; Shetty, H.; Hotopf, M.; Ford, T.; Kyriakopoulos, M.; Diaz-Caneja, CM.; Arango, C.; MacCabe, JH.; Hayes, RD.; Pina-Camacho, L.	Schizophrenia Bulletin.

Predictors of Placebo Response in Pharmacological Clinical Trials of Negative Symptoms in Schizophrenia: A Meta-regression Analysis	2018	Fraguas, D.; Díaz-Caneja, CM.; Pina-Camacho, L.; Umbricht, D.; Arango C.	Schizophrenia Bulletin.

A quantitative approach to neuropsychiatry: the why and the how	2017	Kas, MJ.; Penninx, B.; Sommer, B.; Serretti, A.; Arango, C.; Marston H.	Neuroscience & Biobehavioral Reviews

Duration of untreated psychosis and neurocognitive functioning in first-episode psychosis: a systematic review and meta-analysis	2017	Allott, K.; Fraguas, D.; Bartholomeusz, CF.; Díaz-Caneja, CM.; Wannan, C.; Parrish, EM.; Amminger, GP.; Pantelis, C.; Arango, C.; McGorry, PD.; Rapado-Castro, M.	Psychological Medicine

Personality organization and its association with clinical and functional features in borderline personality disorder	2017	Esguevillas Á, Díaz-Caneja CM, Arango C, Rey-Mejías ÁLD, Bernardo EG, Delgado C, Clarkin JF, Carrasco JL.	Psychiatry Research

Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group	2017	Kelly, S.; Jahanshad, N.; et al.	Molecular Psychiatry

Early Intervention in Psychosis: From Clinical Intervention to Health System Implementation	2017	Csillag, C.; Norentoft, M.; Mizuno, M.; McDaid, D.; Arango, C.; Smith, Jo; Lora, A.; Verma, S.; di Fiandra, T.; Jones, P.B.	Early Intervention in Psychiatry

A Psychopathological Comparison between Delusional Disorder and Schizophrenia	2017	Muñoz-Negro, JE.; Ibáñez-Casas, I.; de Portugal, E.; Lozano-Gutiérrez, V.; Martínez-Leal, R.; Cervilla, JA.	Canadian Journal of Psychiatry

Science and fashion: inflammation and oxidative stress in psychiatry	2017	Arango, C.	European Archives of Psychiatry and Clinical Neuroscience

Treated Incidence of Psychotic Disorders in the Multinational EU-GEI Study	2017	Jongsma, HE.; Gayer-Anderson, C.; Lasalvia, A.; Quattrone, D.; Mulè, A.; Szöke, A.; Selten, JP.; Turner, C.; Arango, C.; Tarricone, I.; Berardi, D.; Tortelli, A.; Llorca, PM.; de Haan, L.; Bobes, J.; Bernardo, M.; Sanjuán, J.; Santos, JL.; Arrojo, M.; Del-Ben, CM.; Menezes, PR.; Murray, RM.; Rutten, BP.; Jones, PB.; van Os, J.; Morgan, C.; Kirkbride, JB; European Network of National Schizophrenia Networks Studying Gene-Environment Interactions Work Package 2 (EU-GEI WP2) Group.	JAMA Psychiatry
Gray matter changes and cognitive predictors of 2-year follow-up abnormalities in early-onset first-episode psychosis	2017	Castro-Fornieles, J.; Bargalló, N.; Calvo, A.; Arango, C.; Baeza, I.; Gonzalez-Pinto, A.; Parellada, M.; Graell, M.; Moreno, C.; Otero, S.; Janssen, J.; Rapado-Castro, M.; de la Serna, E.	European Child and Adolescent Psychiatry

Risk factors and peripheral biomarkers for schizophrenia spectrum disorders: an umbrella review of meta-analyses	2017	Belbasis, L.; Köhler, CA.; Stefanis, N.; Stubbs, B.; van Os, J.; Vieta, E.; Seeman, MV.; Arango, C.; Carvalho, AF.; Evangelou, E..	Acta Psychiatrica Scandinavica

Effects of functional remediation on neurocognitively impaired bipolar patients: enhancement of verbal memory	2016	Bonnin, CM.; Reinares, M.; Martínez-Arán, A.; Balanzá-Martínez, V.; Sole, B.; Torrent, C.; Tabarés-Seisdedos, R.; García-Portilla, MP.; Ibáñez, A.; Amann, BL.; Arango, C.; Ayuso-Mateos, JL.; Crespo, JM.; González-Pinto, A.; Colom, F.; Vieta, E; CIBERSAM F.	Psychological Medicine
BDNF and NGF Signalling in Early Phases of Psychosis: Relationship With Inflammation and Response to Antipsychotics After 1 Year	2016	Martinez-Cengotitabengoa, M.; MacDowell, KS.; Alberich, S.; Diaz, FJ.; Garcia-Bueno, B.; Rodriguez-Jimenez, R.; Bioque, M.; Berrocoso, E.; Parellada, M.; Lobo, A.; Saiz, PA.; Matute, C.; Bernardo, M.; Gonzalez-Pinto, A.; Leza, JC; FLAMM-PEPs.	Schizophrenia Bulletin
Neuropsychological characteristics of child and adolescent offspring of patients with bipolar disorder	2016	de la Serna, E.; Vila, M.; Sanchez-Gistau, V.; Moreno, D.; Romero, S.; Sugranyes, G.; Baeza, I.; Llorente, C.; Rodriguez-Toscano, E.; Sánchez-Gutierrez, T.; Castro-Fornieles, J. Progress in	Neuropsychopharmacology & Biological Psychiatry
Functional remediation in bipolar disorder: 1-year follow-up of neurocognitive and functional outcome	2016	Bonnin, CM.; Torrent, C.; Arango, C.; Amann, BL.; Solé, B.; González-Pinto, A.; Crespo, JM.; Tabarés-Seisdedos, R.; Reinares, M.; Ayuso-Mateos, JL.; García-Portilla, MP.; Ibañez, Á.; Salamero, M.; Vieta, E.; Martinez-Aran, A; CIBERSAM Functional Remediation Group	British Journal of Psychiatry
Executive function is affected in autism spectrum disorder, but does not correlate with intelligence	2016	Merchán-Naranjo, J.; Boada, L.; Del Rey-Mejías, Á.; Mayoral, M.; Llorente, C.; Arango, C.; Parellada, M.	Revista de Psiquiatría y Salud Mental

Cognitive reserve in bipolar disorder: relation to cognition, psychosocial functioning and quality of life	2016	Anaya, C.; Torrent, C.; Caballero, FF.; Vieta, E.; Bonnin, CD.; Ayuso-Mateos, JL; CIBERSAM Functional Remediation Group	Acta Psychiatrica Scandinavica

Building up careers: education and training in translational neuroscience and mental health research	2015	Rapado-Castro, M.; Pazos, A.; Fañanás, L.; Bernardo, M.; Ayuso-Mateos, JL.; Leza, JC.; Berrocoso, E.; Arriba-Enriquez, J.; Roldán, L.; Sanjuán, J.; Pérez, V.; Haro, JM.; Palomo, T.; Valdizan, E.; Micó, JA.; Sánchez, M.; Arango, C.	Revista de Psiquiatría y Salud Mental
Towards stage specific treatments: Effects of duration of illness on therapeutic response to adjunctive treatment with N-acetyl cysteine in schizophrenia.	2015	Rapado-Castro, M.; Berk, M.; Venugopal, K.; Bush, A.; Dodd, S.; Dean, O.	Progress in Neuropsychopharmacology & Biological Psychiatry

Progressive brain changes in children and adolescents with early-onset psychosis: A meta-analysis of longitudinal MRI studies	2015	Fraguas, D.; Díaz-Caneja, CM.; Pina-Camacho, L.; Janssen, J.; Arango, C	Schizophrenia Research

Gender effects on brain changes in early-onset psychosis	2015	Rapado-Castro, M.; Bartholomeusz, CF.; Castro-Fornieles, J.; González-Pinto, A.; Otero, S.; Baeza, I.; Moreno, C.; Graell, M.; Janssen, J.; Bargalló, N.; Pantelis, C.; Desco, M.; Arango, C	European Child and Adolescent Psychiatry
Cognitive Decline Preceding the Onset of Psychosis in Patients with 22q11.2 Deletion Syndrome	2015	Vorstman, JA.; Breetvelt, EJ.; Duijff, SN.; Eliez, S.; Schneider, M.; Jalbrzikowski, M.; Armando, M.; Vicari, S.; Shashi, V.; Hooper, SR.; Chow, EW.; Fung, WL.; Butcher, NJ.; Young, DA.; McDonald-McGinn, DM.; Vogels, A.; van, Amelsvoort, T.; Gothelf, D.; Weinberger, R.; Weizman, A.; Klaassen, PW.; Koops, S.; Kates, WR.; Antshel, KM.; Simon, TJ.; Ousley, OY.; Swillen, A.; Gur, RE.; Bearden, CE.; Kahn, RS.; Bassett, AS.; for the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome	JAMA Psychiatry
Functional deterioration from the premorbid period to 2 years after the first episode of psychosis in early-onset psychosis	2015	Del Rey-Mejías, Á.; Fraguas, D.; Díaz-Caneja, CM.; Pina-Camacho, L.; Castro-Fornieles, J.; Baeza, I.; Espliego, A.; Merchán-Naranjo, J.; González-Pinto, A.; de, la, Serna, E.; Payá, B.; Graell, M.; Arango, C.; Parellada, M.	European Child and Adolescent Psychiatry
Magnetic Resonance Imaging and the Prediction of Outcome in First-Episode Schizophrenia: A Review of Current Evidence and Directions for Future Research 2015	2015	Dazzan, P.; Arango, C.; Fleischacker, W.; Galderisi, S.; Glenthøj, B.; Leucht, S.; Meyer-Lindenberg, A.; Kahn, R.; Rujescu, D.; Sommer, I.; Winter, I.; McGuire, P.	Schizophrenia Bulletin

Premorbid adjustment and clinical correlates of cognitive impairment in first-episode psychosis. The PEPsCog Study.	2015	Cuesta, MJ.; Sánchez-Torres, AM.; Cabrera, B.; Bioque, M.; Merchán-Naranjo, J.; Corripio, I.; González-Pinto, A.; Lobo, A.; Bombín, I.; de la Serna, E.; Sanjuan, J.; Parellada, M.; Saiz-Ruiz, J.; Bernardo, M.	Schizophrenia Research
The Promise of Biological Markers for Treatment Response in First-Episode Psychosis: A Systematic Review	2015	Fond, G.; d'Albis, MA.; Jamain, S.; Tamouza, R.; Arango, C.; Fleischhacker, WW.; Glenthøj, B.; Leweke, M.; Lewis, S.; McGuire, P.; Meyer-Lindenberg, A.; Sommer, IE.; Winter-van, Rossum, I.; Kapur, S.; Kahn, RS.; Rujescu, D.; Leboyer, M.	Schizophrenia Bulletin
The Optimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) Trial: Rationale for its Methodology and a Review of the Effectiveness of Switching Antipsychotics	2015	Leucht, S.; Winter-van Rossum, I.; Heres, S.; Arango, C.; Fleischhacker, WW.; Glenthøj, B.; Leboyer, M.; Leweke, FM.; Lewis, S.; McGuire, P.; Meyer-Lindenberg, A.; Rujescu, D.; Kapur, S.; Kahn, RS.; Sommer, IE.	Schizophrenia Bulletin

Modeling Determinants of Medication Attitudes and Poor Adherence in Early Nonaffective Psychosis: Implications for Intervention	2015	Drake, RJ.; Nordentoft, M.; Haddock, G.; Arango, C.; Fleischhacker, WW.; Glenthøj, B.; Leboyer, M.; Leucht, S.; Leweke, M.; McGuire, P.; Meyer-Lindenberg, A.; Rujescu, D.; Sommer, IE.; Kahn, RS.; Lewis, SW.	Schizophrenia Bulletin
Predictors of outcome in early-onset psychosis: a systematic review	2015	Díaz-Caneja, C.; Pina-Camacho, L.; Rodríguez-Quiroga, A.; Fraguas, D.; Parellada, M.; Arango, C.	NPJ Schizophrenia

The impact of neuropsychological functioning and coping style on perceived stress in individuals with first-episode psychosis and healthy controls	2015	Allott, KA.; Rapado-Castro, M.; Proffitt, TM.; Bendall, S.; Garner, B.; Butselaar, F.; Markulev, C.; Phassouliotis, C.; McGorry, PD.; Wood, SJ.; Cotton, SM.; Phillips, LJ.	Psychiatry Research

Bipolar I and II versus unipolar depression: Clinical differences and impulsivity/aggression traits	2015	Dervic, K.; Garcia-Amador, M.; Sudol, K.; Freed, P.; Brent, D.; Mann, JJ.; Harkavy-Friedman, JM.; Oquendo, MA.	European Psychiatry

Functional remediation for patients with bipolar II disorder: Improvement of functioning and subsyndromal symptoms	2015	Solé B, Bonnin CM, Mayoral M, Amann BL, Torres I, González-Pinto A, Jimenez E, Crespo JM, Colom F, Tabarés-Seisdedos R, Reinares M, Ayuso-Mateos JL, Soria S, Garcia-Portilla MP, Ibañez A, Vieta E, Martinez-Aran A, Torrent C; the CIBERSAM Functional Remediation Group.	European Neuropsychopharmacology

Predictors of schizophrenia spectrum disorders in early-onset first episodes of psychosis: a support vector machine model	2015	Pina-Camacho L, Garcia-Prieto J, Parellada M, Castro-Fornieles J, Gonzalez-Pinto AM, Bombin I, Graell M, Paya B, Rapado-Castro M, Janssen J, Baeza I, Pozo FD, Desco M, Arango C.	European Child and Adolescent Psychiatry

Present and future of developmental neuropsychopharmacology	2015	Arango C	European Neuropsychopharmacology

The affective dimension of early-onset psychosis and its relationship with suicide	2015	Sanchez-Gistau V, Baeza I, Arango C, González-Pinto A, de la Serna E, Parellada M, Graell M, Paya B, Llorente C, Castro-Fornieles J.	Journal of Child Psychology and Psychiatry

Tobacco Use in Bipolar Disorder	2015	Thomson, D.; Berk, M.; Dodd, S.; Rapado-Castro, M.; Quirk, SE.; Ellegaard, PK.; Berk, L.; Dean Clinical	Psychopharmacology and Neuroscience

Going Beyond "trial-and-error" in Psychiatric Treatments: OPTiMiSE-ing the Treatment of First Episode of Schizophrenia	2015	Arango, C.; Kapur, S.; Kahn, RS	Schizophrenia Bulletin

Inflammation in schizophrenia: A question of balance	2015	Leza, JC.; Bueno, B.; Bioque, M.; Arango, C.; Parellada, M.; Do, K.; O'Donnell, P.; Bernardo M	Neuroscience and Biobehavioral Reviews

Sources of clinical distress in young people at ultra high risk of psychosis	2015	Rapado-Castro, M.; McGorry, P.; Yung, A.; Calvo, A.; Nelson, B.	Schizophrenia Research

Effects of N-Acetyl cysteine on suicidal ideation in bipolar depression	2015	Waterdrinker, A.; Berk, M.; Venugopal, K.; Rapado-Castro, M.; Turner, A.; Dean, OM.	Journal of Clinical Psychiatry

BDNF and NGF Signalling in Early Phases of Psychosis: Relationship With Inflammation and Response to Antipsychotics After 1 Year	2015	Martinez-Cengotitabengoa, M.; MacDowell, KS.; Alberich, S.; Diaz, FJ.; Garcia-Bueno, B.; Rodriguez-Jimenez, R.; Bioque, M.; Berrocoso, E.; Parellada, M.; Lobo, A.; Saiz, PA.; Matute, C.; Bernardo, M.; Gonzalez-Pinto, A.; Leza, JC; FLAMM-PEPs.	Schizophrenia Bulletin

A integral treatment for attention deficit hyperactivity disorder in Europe	2015	Arango, C	Revista de Psiquiatría y Salud Mental

More Treatment for Those Most in Need? A Foregone Conclusion?	2015	Arango C, Kahn RS.	Schizophrenia Bulletin

Reduced Gyrification Is Related to Reduced Interhemispheric Connctivity in Autism Spectrum Disorders	2015	Bos, DJ.; Merchán-Naranjo, J.; Martínez, K.; Pina-Camacho, L.; Balsa, I.; Boada, L.; Schnack, H.; Oranje, B.; Desco, M.; Arango, C.; Parellada, M.; Durston, S.; Janssen, J.	Journal of the American Academy of Child and Adolescent Psychiatry

Gray Matter Volume Decrease Distinguishes Schizophrenia From Bipolar Offspring During Childhood and Adolescence	2015	Sugranyes, G.; de la Serna, E.; Romero, S.; Sanchez-Gistau, V.; Calvo, A.; Moreno, D.; Baeza, I.; Diaz-Caneja, CM.; Sanchez-Gutierrez, T.; Janssen, J.; Bargallo, N.; Castro-Fornieles, J.	Journal of the American Academy of Child and Adolescent Psychiatry

Maternal depression symptoms, unhealthy diet and child emotional-behavioural dysregulation	2015	Pina-Camacho, L.; Jensen, SK.; Gaysina, D.; Barker, ED.	Psychological Medicine

Unmet needs in paediatric psychopharmacology: Present scenario and future perspectives	2015	Persico, AM.; Arango, C.; Buitelaar, JK.; Correll, CU.; Glennon, JC.; Hoekstra, PJ.; Moreno, C.; Vitiello, B.; Vorstman, J.; Zuddas, A; European Child and Adolescent Clinical Psychopharmacology Network.	European Neuropsychopharmacology.

Psychiatric disorders in child and adolescent offspring of patients with schizophrenia and bipolar disorder: A controlled study	2015	Sanchez-Gistau, V.; Romero, S.; Moreno, D.; de la Serna, E.; Baeza, I.; Sugranyes, G.; Moreno, C.; Sanchez-Gutierrez, T.; Rodriguez-Toscano, E.; Castro-Fornieles, J.	Schizophrenia Research

First-Episode Psychosis Research: Time to Move Forward (by Looking Backwards)	2015	Arango, C.	Schizophrenia Bulletin

Neuropsychological characteristics of child and adolescent offspring of patients with bipolar disorder	2015	de la Serna, E.; Vila, M.; Sanchez-Gistau, V.; Moreno, D.; Romero, S.; Sugranyes, G.; Baeza, I.; Llorente, C.; Rodriguez-Toscano, E.; Sánchez-Gutierrez, T.; Castro-Fornieles, J.	Progress in Neuropsychopharmacology & Biological Psychiatry

Age at first episode modulates diagnosis-related structural brain abnormalities in psychosis	2015	Pina-Camacho, L.; Rey-Mejías, A. Del; Janssen, J.; Bioque, M.; González-Pinto, A.; Arango, C.; Lobo, A.; Sarró, A.; Desco, M.; Sanjuan, J.; Lacalle-Aurioles, M.; Cuesta, MJ.; Saiz-Ruiz, J.; Bernardo, M.; Parellada, M.; PEPs Group.	Schizophrenia Bulletin

Effects of functional remediation on neurocognitively impaired bipolar patients: enhancement of verbal memory	2015	Bonnin, CM.; Reinares, M.; Martínez-Arán, A.; Balanzá-Martínez, V.; Sole, B.; Torrent, C.; Tabarés-Seisdedos, R.; García-Portilla, MP.; Ibáñez, A.; Amann, BL.; Arango, C.; Ayuso-Mateos, JL.; Crespo, JM.; González-Pinto, A.; Colom, F.; Vieta, E; CIBERSAM F.	Psychological Medicine

Mental health research priorities for Europe	2015	Wykes, T.; Haro, JM.; Belli, SR.; Obradors-Tarragó, C.; Arango C.; Ayuso-Mateos JL.; Bitter, I.; Brunn, M.; Chevreul, K.; Demotes-Mainard, J.; Elfeddali, I.; Evans-Lacko, S.; Fiorillo, A.; Forsman, AK.; Hazo, JB.; Kuepper, R.; Knappe, S.; Leboyer, M.; Lew.	Lancet Psychiatry

Services for people at high risk improve outcomes in patients with first episode psychosis	2015	Fusar-Poli, P.; Díaz-Caneja, CM.; Patel, R.; Valmaggia, L.; Byrne, M.; Garety, P.; Shetty, H.; Broadbent, M.; Stewart, R.; McGuire, P.	Acta Psychiatrica Scandinavica





The Neurobiology of Autism Spectrum disorders.	2014	Parellada, M.; Penzol, MJ.; Pina, L.; Moreno, C.; Gonzalez-Vioque, E.; Salsean, G.; Arango, C.	European Psychiatry.29 (2014) 11-19. (F.I.: 3.285).
Movie for the Assessment of Social Cognition (MASC): Spanish Validation.	2014	Lahera G, Boada L, Pousa E, Mirapeix I, Morón-Nozaleda G, Marinas L, Gisbert L, Pamiàs M, Parellada M.	J Autism Dev Disord. 2014 Feb 13. [Epub ahead of print].
Synaptic, transcriptional and chromatin genes disrupted in autism.	2014	De Rubeis, S.; He, X.; Goldberg, AP.; Poultney, CS.; Samocha, K.; Ercument Cicek, A.; Kou,Y.; Liu, L.; Fromer, M.; Walker, S.; Singh, T.; Klei, L.; Kosmicki, J.; Fu, SC.; Aleksic, B.; Biscaldi, M.;Bolton, PF.; Brownfeld, JM.; Cai, J.; Campbell, NG.; Carracedo, A.; Chahrour, MH.; Chiocchetti, AG.;Coon, H.; Crawford, EL.; Crooks, L.; Curran, SR.; Dawson, G.; Duketis, E.; Fernandez, BA.;Gallagher, L.; Geller, E.; Guter, SJ.; Sean Hill, R.; Ionita-Laza, I.; Jimenez Gonzalez, P.; Kilpinen, H.;Klauck, SM.; Kolevzon, A.; Lee, I.; Lei, J.; Lehtimäki, T.; Lin, CF.; Ma'ayan, A.; Marshall, CR.;McInnes, AL.; Neale, B.; Owen, MJ.; Ozaki, N.; Parellada, M.; Parr, JR.; Purcell, S.; Puura, K.;Rajagopalan, D.; Rehnström, K.; Reichenberg, A.; Sabo, A.; Sachse, M.; Sanders, SJ.; Schafer, C.;Schulte-Rüther, M.; Skuse, D.; Stevens, C.; Szatmari, P.; Tammimies, K.; Valladares, O.; Voran, A.;Wang, LS.; Weiss, LA.; Jeremy, Willsey.; Yu, TW.; Yuen, RK.; DDD Study; Homozygosity MappingCollaborative for Autism; UK10K Consortium; Autism Sequencing Consortium; Cook, EH.; Freitag,CM.; Gill, M.; Hultman, CM.; Lehner, T.; Palotie, A.; Schellenberg, GD.; Sklar, P.; State, MW.;Sutcliffe, JS.; Walsh, CA.; Scherer, SW.; Zwick, ME.; Barrett, JC.; Cutler, DJ.; Roeder, K.; Devlin, B.;Daly, MJ.; Buxbaum, JD.	Nature
Duration of untreated psychosis predicts functional and clinical outcome in children and adolescents with first-episode psychosis: A 2-year longitudinal study	2014	Fraguas D., Del Rey-Mejías A., Moreno C., Castro-Fornieles J., Graell M4, Otero S., Gonzalez-Pinto A., Moreno D., Baeza I., Martínez-Cengotitabengoa M., Arango C., Parellada M.	Schizophr Res. 2014 Jan;152(1):130-8. doi: 10.1016/j.schres.2013.11.018. Epub 2013 Dec 9
The effects of second-generation antipsychotics on food intake, resting energy expenditure and physical activity.	2014	Cuerda C., Velasco C., Merchán-Naranjo J., García-Peris P., Arango C.	Eur J Clin Nutr. 2014 Feb;68(2):146-52. doi: 10.1038/ejcn.2013.253. Epub 2013 Dec 11.
Differential neurodevelopmental trajectories in patients with early-onset bipolar and schizophrenia disorders.	2014	Arango, C.; Fraguas, D.; Parellada, M.	Schizophrenia Bulletin. (en prensa). (F.I.: 8.486).

Common variant at 16p11.2 conferring risk of psychosis.	2014	Steinberg, S.; de Jong, S.; Mattheisen, M.; Costas, J.; Demontis, D.; Jamain, S.; Pietiläinen, OP.; Lin, K.; Papiol, S.; Huttenlocher, J.; Sigurdsson, E.; Vassos, E.; Giegling, I.; Breuer, R.; Fraser, G.; Walker, N.; Melle, I.; Djurovic, S.; Agartz, I.; Tuulio-Henriksson, A.; Suvisaari, J.; Lönnqvist, J.; Paunio, T.; Olsen, L.; Hansen, T.; Ingason, A.; Pirinen, M.; Strengman, E.; Hougaard, DM.; Orntoft, T.; Didriksen, M.; Hollegaard, MV.; Nordentoft, M.; Abramova, L.; Kaleda, V.; Arrojo, M.; Sanjuán, J.; Arango, C.; Etain, B.; Bellivier, F.; Méary, A.; Schürhoff, F.; Szoke, A.; Ribolsi, M.; Magni, V.; Siracusano, A.; Sperling, S.; Rossner, M.; Christiansen, C.; Kiemeney, LA.; Franke, B.; van den Berg, LH.; Veldink, J.; Curran, S.; Bolton, P.; Poot, M.; Staal, W.; Rehnstrom, K.; Kilpinen, H.; Freitag, CM.; Meyer, J.; Magnusson, P.; Saemundsen, E.; Martsenkovsky, I.; Bikshaieva, I.; Martsenkovska, I.; Vashchenko, O.; Raleva, M.; Paketchieva, K.; Stefanovski, B.; Durmishi, N.; Pejovic Milovancevic, M.; Lecic Tosevski, D.; Silagadze, T.; Naneishvili, N.; Mikeladze, N.; Surguladze, S.; Vincent, JB.; Farmer, A.; Mitchell, PB.; Wright, A.; Schofield, PR.; Fullerton, JM.; Montgomery, GW.; Martin, NG.; Rubino, IA.; van Winkel, R.; Kenis, G.; De Hert, M.; Réthelyi, JM.; Bitter, I.; Terenius, L.; Jönsson, EG.; Bakker, S.; van Os, J.; Jablensky, A.; Leboyer, M.; Bramon, E.; Powell, J.; Murray, R.; Corvin, A.; Gill, M.; Morris, D.; O'Neill, FA.; Kendler, K.; Riley, B; Wellcome Trust Case Control Consortium 2.; Craddock, N.; Owen, MJ.; O'Donovan, MC.; Thorsteinsdottir, U.; Kong, A.; Ehrenreich, H.; Carracedo, A.; Golimbet, V.; Andreassen, OA.; Børglum, AD.; Mors, O.; Mortensen, PB.; Werge, T.; Ophoff, RA.; Nöthen, MM.; Rietschel, M.; Cichon, S.; Ruggeri, M.; Tosato, S.; Palotie, A.; St Clair, D.; Rujescu, D.; Collier, DA.; Stefansson, H.; Stefansson K	Molecular Psychiatry
Intervention for Adolescents With Early Onset Psychosis and Their Families: A Randomized Controlled Trial. The PIENSA program.	2014	Ana Calvo, Miguel Moreno, Ana Ruiz-Sancho, Marta Rapado-Castro, Carmen Moreno, Teresa Sánchez-Gutiérrez, Celso Arango, María Mayoral.	Journal of the American Academic of Child and Adolescent Psychiatric

Schizophrenia—Time to Commit to Policy Change	2014	W. Wolfgang Fleischhacker, Celso Arango, Paul Arteel, Thomas R. E. Barnes, William Carpenter, Ken Duckworth, Silvana Galderisi, Lisa Halpern, Martin Knapp, Stephen R. Marder, Mary Moller, Norman Sartorius, and Peter Woodruff	Schizophrenia Bulletin vol. 40 suppl. no. 3 pp. S165–S194, 2014

Pro-/Anti-inflammatory Dysregulation in Patients with First Episode of Psychosis: Toward an Integrative Inflammatory Hypothesis of Schizophrenia	2014	García-Bueno, B.; Bioque M.; Mac-Dowell, KS.; Barcones, MF., Monica Martínez-Cengotitabengoa, Laura Pina-Camacho, Roberto Rodríguez-Jiménez, Pilar A. Sáiz, Carmen Castro, Amalia Lafuente, Javier Santabárbara, Ana González-Pinto, Mara Parellada, Gabriel Rubio, M.Paz Garcia-Portilla, Juan A. Micó, Miguel Bernardo, Juan C. Leza	Schizophrenia Bulletin
Basal low antioxidant capacity correlates with cognitive deficits in earlyonset psychosis. A 2-year follow-up study	2014	Mónica Martínez-Cengotitabengoa, Juan Antonio Micó, Celso Arango, Josefina Castro-Fornieles, Montserrat Graell, Beatriz Payá, Juan Carlos Leza, Iñaki Zorrilla, Mara Parellada, Mª. Purificación López, Inmaculada Baeza, Carmen Moreno, Marta Rapado-Castro, Ana González-Pinto	Schizophrenia Research 156 (2014) 23–29

Oxidative/Nitrosative Stress in Psychiatric Disorders: Are We There Yet?	2014	O'Donnell P, Do KQ, Arango C.	Schizophr Bull. 2014 Apr 8.

Cortical morphology of adolescents with bipolar disorder and with schizophrenia	2014	Janssen J, Alemán-Gómez Y, Schnack H, Balaban E, Pina-Camacho L, Alfaro-Almagro F, Castro-Fornieles J, Otero S, Baeza I, Moreno D, Bargalló N, Parellada M, Arango C, Desco M.	Schizophrenia Research
A longitudinal study on the relationship between duration of untreated psychosis and executive function in early-onset first-episode psychosis	2014	Fraguas D, Merchán-Naranjo J, Del Rey-Mejías A, Castro-Fornieles J, González-Pinto A, Rapado-Castro M, Pina-Camacho L, Díaz-Caneja CM, Graell M, Otero S, Baeza I, Moreno C, Martínez-Cengotitabengoa M, Rodríguez-Toscano E, Arango C, Parellada M.	Schizophrenia Research
Development of the Spanish Brief-version of the University of California Performance Skills Assessment (Sp-UPSA-Brief) in patients with schizophrenia and bipolar disorder	2014	Garcia-Portilla MP, Gomar J, Bobes-Bascaran MT, Menendez-Miranda I, Saiz PA, Muñiz J, Arango C, Patterson T, Harvey P, Bobes J, Goldberg T.	Revista de Psiquiatría y Salud Mental

Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations	2014	European Network of National Networks studying Gene-Environment Interactions in Schizophrenia (EU-GEI), van Os J, Rutten BP, Myin-Germeys I, Delespaul P, Viechtbauer W, van Zelst C, Bruggeman R, Reininghaus U, Morgan C, Murray RM, Di Forti M, McGuire P, Valmaggia LR, Kempton MJ, Gayer-Anderson C, Hubbard K, Beards S, Stilo SA, Onyejiaka A, Bourque F, Modinos G, Tognin S, Calem M, O'Donovan MC, Owen MJ, Holmans P, Williams N, Craddock N, Richards A, Humphreys I, Meyer-Lindenberg A, Leweke FM, Tost H, Akdeniz C, Rohleder C, Bumb JM, Schwarz E, Alptekin K, Üçok A, Saka MC, Atbaşoğlu EC, Gülöksüz S, Gumus-Akay G, Cihan B, Karadağ H, Soygür H, Cankurtaran EŞ, Ulusoy S, Akdede B, Binbay T, Ayer A, Noyan H, Karadayı G, Akturan E, Ulaş H, Arango C, Parellada M, Bernardo M, Sanjuán J, Bobes J, Arrojo M, Santos JL, Cuadrado P, Rodríguez Solano JJ, Carracedo A, García Bernardo E, Roldán L, López G, Cabrera B, Cruz S, Díaz Mesa EM, Pouso M, Jiménez E, Sánchez T, Rapado M, González E, Martínez C, Sánchez E, Olmeda MS, de Haan L, Velthorst E, van der Gaag M, Selten JP, van Dam D, van der Ven E, van der Meer F, Messchaert E, Kraan T, Burger N, Leboyer M, Szoke A, Schürhoff F, Llorca PM, Jamain S, Tortelli A, Frijda F, Vilain J, Galliot AM, Baudin G, Ferchiou A, Richard JR, Bulzacka E, Charpeaud T, Tronche AM, De Hert M, van Winkel R, Decoster J, Derom C, Thiery E, Stefanis NC, Sachs G, Aschauer H, Lasser I, Winklbaur B, Schlögelhofer M, Riecher-Rössler A, Borgwardt S, Walter A, Harrisberger F, Smieskova R, Rapp C, Ittig S, Soguel-dit-Piquard F, Studerus E, Klosterkötter J, Ruhrmann S, Paruch J, Julkowski D, Hilboll D, Sham PC, Cherny SS, Chen EY, Campbell DD, Li M, Romeo-Casabona CM, Emaldi Cirión A, Urruela Mora A, Jones P, Kirkbride J, Cannon M, Rujescu D, Tarricone I, Berardi D, Bonora E, Seri M, Marcacci T, Chiri L, Chierzi F, Storbini V, Braca M, Minenna MG, Donegani I, Fioritti A, La Barbera D, La Cascia CE, Mulè A, Sideli L, Sartorio R, Ferraro L, Tripoli G, Seminerio F, Marinaro AM, McGorry P, Nelson B, Amminger GP, Pantelis C, Menezes PR, Del-Ben CM, Gallo Tenan SH, Shuhama R, Ruggeri M, Tosato S, Lasalvia A, Bonetto C, Ira E, Nordentoft M, Krebs MO, Barrantes-Vidal N, Cristóbal P, Kwapil TR, Brietzke E, Bressan RA, Gadelha A, Maric NP, Andric S, Mihaljevic M, Mirjanic T.	Schizophrenia Bulletin
Double-blind, placebo-controlled study of the efficacy of reboxetine and citalopram as adjuncts to atypical antipsychotics for negative symptoms of schizophrenia	2014	Usall J, López-Carrilero R, Iniesta R, Roca M, Caballero M, Rodriguez-Jimenez R, Oliveira C, Bernardo M, Corripio I, Sindreu SD, González Piqueras JC, Felipe AE, Fernandez de Corres B, Ibáñez A, Huerta R; Abordaje Síntomas Negativos Esquizofrenia (ASINE) Group	Journal of Clinical Psychiatry
Antipsychotic Use in Children and Adolescents: A 1-Year Follow-Up Study	2014	Baeza I, de la Serna E, Calvo-Escalona R, Morer A, Merchán-Naranjo J, Tapia C, Martínez-Cantarero MC, Andrés P, Alda JA, Sánchez B, Arango C, Castro-Fornieles J.	Journal of Clinical Psychopharmacology
Paediatric European Risperidone Studies (PERS): context, rationale, objectives, strategy, and challenges	2014	Glennon J, Purper-Ouakil D, Bakker M, Zuddas A, Hoekstra P, Schulze U, Castro-Fornieles J, Santosh PJ, Arango C, Kölch M, Coghill D, Flamarique I, Penzol MJ, Wan M, Murray M, Wong ICK, Danckaerts M, Bonnot O, Falissard B, Masi G, Fegert JM, Vicari S, Carucci s, Dittmann RW, Buitelaar JK, and the PERS Consortium	European Child and Adolescent Psychiatry
Predictors of schizophrenia spectrum disorders in early-onset first episodes of psychosis: a support vector machine model	2014	Pina-Camacho L, Garcia-Prieto J, Parellada M, Castro-Fornieles J, Gonzalez-Pinto AM, Bombin I, Graell M, Paya B, Rapado-Castro M, Janssen J, Baeza I, Pozo FD, Desco M, Arango C	European Child and Adolescent Psychiatry

Replication of previous genome-wide association studies of psychiatric diseases in a large schizophrenia case–control sample from Spain	2014	Ivorra JL, Rivero O, Costas J, Iniesta R, Arrojo M, Ramos-Ríos R, Carracedo A, Palomo T, Rodriguez-Jimenez R, Cervilla J, Gutiérrez B, Molina E, Arango C, Álvarez M, Pascual JC, Pérez V, Saiz PA, García-Portilla MP, Bobes J, González-Pinto A, Zorrilla I, Haro JM, Bernardo M, Baca-García E, González JC, Hoenicka J, Moltó MD.	Schizophrenia Research
The affective dimension of early-onset psychosis and its relationship with suicide	2014	Sanchez-Gistau V, Baeza I, Arango C, González-Pinto A, de la Serna E, Parellada M, Graell M, Paya B, Llorente C, Castro-Fornieles J.	Journal of Child Psychology and Psychiatry
Functional remediation for patients with bipolar II disorder: Improvement of functioning and subsyndromal symptoms	2014	Solé B, Bonnin CM, Mayoral M, Amann BL, Torres I, González-Pinto A, Jimenez E, Crespo JM, Colom F, Tabarés-Seisdedos R, Reinares M, Ayuso-Mateos JL, Soria S, Garcia-Portilla MP, Ibañez A, Vieta E, Martinez-Aran A, Torrent C; the CIBERSAM Functional Remediation Group.	European Neuropsychopharmacology
More Treatment for Those Most in Need? A Foregone Conclusion?	2014	Arango C, Kahn RS	Schizophrenia Bulletin

Second-Generation Antipsychotic Use in Children and Adolescents: A Six-Month Prospective Cohort Study in Drug-Naïve Patients	2014	Arango, C.; Giráldez, M.; Merchán-Naranjo, J.; Baeza, I.; Castro-Fornieles, J.; Alda, JA.; Martínez-Cantarero, C.; Moreno, C; de Andrés, P; Cuerda, C; de la Serna, E; Correll, C.; Fraguas, D.;	Journal of the American Academy of Child and Adolescent Psychiatry

Present and future of developmental neuropsychopharmacology	2014	Arango C	European Neuropsychopharmacology

Bipolar I and II versus unipolar depression: Clinical differences and impulsivity/aggression traits	2014	Dervic, K.; Garcia-Amador, M.; Sudol, K.; Freed, P.; Brent, D.; Mann, JJ.; Harkavy-Friedman,	European Psychiatry

Schizophrenia International Research Society Conference, 5-9 April 2014, Florence, Italy: A summary of topics and trends		Abayomi, O.; Amato, D.; Bailey, C.; Bitanihirwe, B.; Bowen, L.; Burshtein, S.; Cullen, A.; Fusté, M.; Herrmann, AP.; Khodaie, B.; Kilian, S.; Lang, QA.; Manning, EE.; Massuda, R.; Nurjono, M.; Sadiq, S.; Sanchez-Gutierrez, T.; Sheinbaum, T.; Shivakumar, V.; Simon, N.; Spiteri-Staines, A.; Sirijit, S.; Toftdahl, NG.; Wadehra, S.; Wang, Y.; Wigton, R.; Wright, S.; Yagoda, S.; Zaytseva, Y.; O'Shea, A.; DeLisi, LE.	Schizophrenia Research
Tobacco Use in Bipolar Disorder	2014	Thomson, D.; Berk, M.; Dodd, S.; Rapado-Castro, M.; Quirk, SE.; Ellegaard, PK.; Berk, L.; Dean, OM.	Clinical Psychopharmacology and Neuroscience

A Pharmacogenetic study of Second-generation antipsychotic Long-tem treatment Metabolic side effects (The SLiM study): rationale, objectives, and design		Pina-Camacho, L.; Díaz-Caneja, CM.; Saiz, PA.; Bobes, J.; Corripio, I.; Grasa, E.; Rodriguez-Jimenez, R.; Fernández, M.; Sanjuán, J.; García-López, A.; Tapia-Casellas, C.; Álvarez-Blázquez, M.;Fraguas, D.; Mitjans, M.; Arias, B.; Arango, C	Revista de Psiquiatría y Salud Mental

ROAMER: roadmap for mental health research in Europe	2014	Haro JM, Ayuso-Mateos JL, Bitter I, Demotes-Mainard J, Leboyer M, Lewis SW, Linszen D, Maj M, McDaid D, Meyer-Lindenberg A, Robbins TW, Schumann G, Thornicroft G, Van Der Feltz-Cornelis C, Van Os J, Wahlbeck K, Wittchen HU, Wykes T, Arango C, Bickenbach J, Brunn M, Cammarata P, Chevreul K, Evans-Lacko S, Finocchiaro C, Fiorillo A, Forsman AK, Hazo JB, Knappe S, Kuepper R, Luciano M, Miret M, Obradors-Tarragó C, Pagano G, Papp S, Walker-Tilley T.	Int J Methods Psychiatr Res. 2014 Jan;23 Suppl 1:1-14. doi: 10.1002/mpr.1406.
White matter microstructure correlates of mathematical giftedness and intelligence quotient	2014	Navas-Sánchez, FJ.; Alemán-Gómez, Y.; Sánchez-Gonzalez, J.; Guzmán-De-Villoria, JA.; Franco, C.; Robles, O.; Arango, C.; Desco, M.	Human Brain Mapping

Verbal memory as a mediator in the relationship between subthreshold depressive symptoms and functional outcome in bipolar disorder	2014	Bonnín Cdel M, González-Pinto A, Solé B, Reinares M, González-Ortega I, Alberich S, Crespo JM, Salamero M, Vieta E, Martínez-Arán A, Torrent C	CIBERSAM Functional Remediation Group. J Affect Disord. 2014 May;160:50-4. doi: 10.1016/j.jad.2014.02.034. Epub 2014 Mar 11.

Polypharmacy with antidepressants in children and adolescents	2014	Díaz-Caneja CM, Espliego A, Parellada M, Arango C, Moreno C.	Int J Neuropsychopharmacol. 2014 17(7):1063-82.

Practitioner Review: Long-term pharmacological treatment of pediatric bipolar disorder	2014	Díaz-Caneja CM, Moreno C, Llorente C, Espliego A, Arango C, Moreno D.	Journal of Child Psychology and Psychiatry
Structural magnetic resonance imaging data do not help support DSM-5 autism spectrum disorder category.	2013	Laura Pina-Camacho, Sonia Villero, Leticia Boada, David Fraguas, Joost Janssen, María Mayoral, Cloe Llorente, Celso Arango, Mara Parellada.	Research in Autism Spectrum Disorders
Specialty Care Programme for autism spectrum disorders in an urban population: A case-management model for health care delivery in an ASD population.	2013	Parellada, M.; Boada, L.; Moreno, C.; Llorente, C.; J. Romo, C. Muela, C.Arango.	European Psychiatry.
Psychopathology in Children and Adolescents with ASD Without Mental Retardation.	2013	Caamaño, M.; Boada L.; Merchán-Naranjo, J.; Moreno, C. Cloe Llorente; Dolores Moreno; Celso Arango; Mara Parellada.	Journal of Autism and Developmental Disorders.
Attitude and risk of substance use in adolescents diagnosed with Asperger syndrome.	2013	Ramos, M.; Boada, L.; Moreno, C.; Llorente, C.; Romo, J.; Parellada, M.	Drug and alcohol dependence. 2013 Dec 1;133(2):535-40 .(F.I.: 3.141).

Assessing clinical and functional outcomes in a gene-environment interaction study in first episode of psychosis (PEPs).	2013	Bernardo, M.; Bioque, M.; Parellada, M.; Saiz Ruiz, J.; Manuel J. Cuesta; Adríán Llerena; Julio Sanjuán; Josefina Castro- Forniels; Celso Arango; Bibiana Cabrera; PEPs GROUP.	Revista de Psiquiatría y Salud Mental
Premorbid impairments in early-onset psychosis: Differences between patients with schizophrenia and bipolar disorder.	2013	Payá, B.; Rodríguez-Sánchez, JM.; Otero, S.; Muñoz, P., Josefina Castro-Fornieles, Mara Parellada, Ana González-Pinto, Cesar Soutullo, Inmaculada Baeza, Marta Rapado-Castro, Margarita Sáenz-herrero, Dolores Moreno, Celso Arango.	Schizophrenia Research.
Evidence for the early clinical relevance of hallucinatory-delusional states in the general population.	2013	Nuevo, R.; Van Os, J.; Arango, C.; Chatterji, S., J.L. Ayuso- Mateos.	Acta Psychiatrica Scandinavica.

Cognition in schizophrenia: Summary Nice Consultation Meeting 2012	2013	Nutt, D.; Gispen-de Wied, CC.; Arango, C.; Keefe, RS, Rafael Penades, Declan G. Murphy, Trevor W Robbins, Barbara j Sahakian	European Neuropsychopharmacology
Twenty-Four Months of Antipsychotic Treatment in Children and Adolescents With First Psychotic Episode - Discontinuation and Tolerability	2013	Ana Noguera, Patricia Ballesta, Immaculada Baeza, Celso Arango, Elena de la Serna, Ana González-Pinto, Mara Parellada, Montserrat Graell, Carmen Moreno, Soraya Otero, Josefina Castro-Fornieles	Journal of Clinical Psychopharmacology

Psychotic symptoms are associated with physical health problems independently of a mental disorder diagnosis: results from the WHO World Health Survey.	2013	Carmen Moreno, Roberto Nuevo, Somnath Chatterji, Emese Verdes, Celso Arango, José Luis Ayuso-Mateos.	World Psychiatry.
A simulation model to estimate 10-year risk of coronary heart disease events in patients with schizophrenia spectrum disorders treated with second-generation antipsychotic drugs.	2013	Darbà, J.; Kaskens, L.; Aranda, P.; Arango, C.; Bobes, J.; Carmena, R.; Rejas, J.	Annals of Clinical Psychiatry, 5(1):17-26, 2013. (F.I.: 1.490).
PIENSA: The development of an Early Intervention Program for Adolescents with Early Onset Psychosis and their families.	2013	Ruiz Sancho, A.; Calvo Calvo, AB.; Rapado Castro, M.; Moreno Iñiguez, M.; Moreno, C.; Sanchez Gutiérrez, T.; Tapia Casellas, C.; Chiclana Actis, G.; Rodriguez La Torre, P.; Fernández, P.; Arango López, C. Mayoral Aragón, M.	Adolescent Psychiatry.
Peripheral endocannabinoid system dysregulation in first-episode psychosis.	2013	Miquel Bioque, Borja Garcı´a-Bueno, Karina S Mac-Dowell, Ana Meseguer, Pilar A. Saiz, Mara Parellada, Ana González-Pinto, Roberto Rodrígue-Jiménez, Antonio Lobo, Juan C.Leza, Miguel Bernardo, CIBERSAM.	Neuropshychopharmacology.
Neuropsychological evidence for abnormal neurodevelopment associated with early onset psychoses.	2013	Bombin, I., Mayoral, M., Castro-Fornieles, J., Gonzalez-Pinto, A., de la Serna, E., Rapado-Castro, M., Barbeito, S., Parellada, M., Baeza, I., Graell, M., Payá, B., Arango, C.	Psychological Medicine, 43(4):757-68, 2013. (F.I.: 5.587).
Validation of a European Spanish-version of the University of California Performance Skills Assessment (Sp-UPSA) in patients with schizophrenia and bipolar disorder.	2013	Garcia-Portilla, MP.; Gomar, JJ.; Bobes-Bascaran, MT.; Menendez-Miranda, I.; Saiz, P.; Muñiz, J.; Arango, C.; Patterson, T.; Harvey, P.; Bobes, J.; Goldberg, T.	Schizophrenia Research, 150(2-3): 421-426, 2013. (F.I.: 4.590).
Social cognition in schizophrenia: from evidence to treatment.	2013	Parellada, M.	American Journal of Psychiatry, 170(10):1216, 2013. (F.I.: 14.721).
Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia.	2013	Marder, SR.; Alphs, L.; Anghelescu, IG.; Arango, C.; Barnes, TR.; Caers, I.; Daniel, DG.; Duneyevich, E.; Fleischhacker, WW.; Garibaldi, G.; Green, MF.; Harvey, PD.; Kahn, RS.; Kane, JM.; Keefe, RS.; Kinon, B.; Leucht, S.; Lindenmayer, JP.; Malhotra, AK.; Stauffer, V.; Umbricht, D.; Wesnes, K.; Kapur, S.; Rabinowitz, J.	Schizophrenia Research. 2013 Nov;150(2-3):328-33 (F.I.: 4.590).
Parents with bipolar disorder: Are disease characteristics good predictors of psychopathology in offspring?.	2013	Garcia-Amador, M.; de la Serna, E.; Vila, M.; Romero, S.; Valenti, M.; Sanchez-Gistau, V.; Benabarre, A.; Vieta E.; Castro-Fornieles, J.	European Psychiatry, 28(4):240-6, 2013. (F.I.: 3.285).
Predictors of suicide attempt in early-onset, first-episode psychoses: a longitudinal 24-month follow-up study.	2013	Sanchez-Gistau, V.; Baeza, I.; Arango, C.; González-Pinto, A.; de la Serna, E.; Parellada, M.; Graell, M.; Paya, B.; Llorente, C.; Castro-Fornieles, J.	Journal of Clinical Psychiatry74(1):59-66, (F.I.: 5.812).
Neuropsychological correlates of P50 sensory gating in patients with schizophrenia.	2013	Sánchez-Morla, EM.; Santos, JL.; Aparicio, A.; García-Jiménez, MA.; Soria, C.; Arango, C.	Schizophrenia Research. 143(1):102-6, 2013. (F.I.: 4.590).
The bipolar-depressive continuum in the National Epidemiologic Survey on Alcohol and Related Conditions.	2013	Moreno, C.; Hasin, DS.; Arango, C.; Oquendo, MA.; Vieta, E.; Liu, S.; Grant, BF.; Blanco, C.	Bipolar Disorders, 15(1):112-113, 2013. (F.I.: 4.621).
Cognitive reserve as a predictor of two year neuropsychological performance in early onset first-episode schizophrenia.	2013	de la Serna, E.; Andrés-Perpiñá, S.; Puig, O.; Baeza, I.; Bombin, I.; Bartrés-Faz, D.; Arango, C.; Gonzalez-Pinto, A.; Parellada, M.; Mayoral, M.; Graell, M.; Otero, S.; Guardia, J.; Castro-Fornieles, J.	Schizophrenia Research. 143(1):125-31, 2013. (F.I.: 4.590).
Risperidone normalizes increased inflammatory parameters and restores anti-inflammatory pathways in a model of neuroinflammation.	2013	Mac-Dowell, KS.; García-Bueno, B.; Madrigal, JLM.; Parellada, M., C. Arango, J.A. Micó, J.C. Leza.	International Journal of Neuropsychopharmacology.
Borderline Intellectual Functioning: Consensus and good practice guidelines.	2013	Salvador-Carulla, L.; García-Gutiérrez, JC.; Ruiz Gutiérrez-Colosía, M.; Artigas-Pallarès, J.; García Ibáñez, J; González Pérez, J; Nadal Pla, M.; Aguilera Inés, F.; Isus, S.; Cereza, J.M.; Poole, M.; Portero Lazcano, G.; Monzón, P.; Leiva, M.; Parellada, M.; García Nonell, K.; Martínez i Hernández, A.; Rigau, E.; Martínez-Leal, R.	Revista de Psiquiatría y Salud Mental.
Why psychogeriatrics starts right after adolescence.	2013	Mara Parellada.	Eur Child Adolesc Psychiatry.
Child neuropsychopharmacology: good news… the glass is half full.	2013	Arango, C.	World Psychiatry, 12(2):128-9, 2013. (F.I.: 8.974).
Empirical redefinition of delusional disorder and its phenomenology: the DELIREMP study.	2013	de Portugal, E.; González, N.; del Amo, V.; Haro, JM.; Díaz-Caneja, CM.; Luna del Castillo, Jde D.; Cervilla, JA.	Comprehensive psychiatry, 54(3):243-55, 2013. (F.I.: 2.376).
Efficacy of Functional Remediation in Bipolar Disorder: A Multicentre, Randomized- Controlled Study.	2013	Torrent, C.; del Mar Bonnin, C.: Martinez-Arán, A.; del Valle, J.; Amann, B.; González-Pinto, A.; Crespo, JM; Ibañez, A.; Garcia-Portilla, MP.; Tabarés-Seisdedos, R.; Arango, C.; Colom, F.; Solé B.; Pacchiarotti, I.; Rosa, AR.; Ayuso-Mateos, JL; Anaya, C; Fernández, P.; Landín-Romero, R; Alonso, S.: Ortiz-Gil, A.; Segura, B.; Barbeito, S.; Vega, S.; Fernández, S.; Ugarte, A.; Subirà, A; Cerrillo, E.; Custal, N.; Menchón, JM.; Saiz-Ruiz, J.; Rodao, MJ.; Isella, S.; Alegría, A.; Al-Halabi, S.; Bobes, J.; Galván, G.; Saiz, PA.; Balanzá-Martínez, V.; Selva, G.; Fuentes-Durá, I.; Correa, P.; Mayoral, M.; Chiclana, G., Merchan-Naranjo, J., Rapado-Castro, M.; Salamero, M.; Vieta, E.	American Journal of Psychiatry, 170(8):852-9, 2013. (F.I.: 14.721).
To treat or not to treat? and How to treat? Two questions whose answers are far removed from evidence informed practice in child psychiatry.	2013	Arango, C.	European Child and Adolescent Psychiatry, 22(9):521-2, 2013. (F.I.: 3.699).
The Human Cerebral Cortex Flattens during Adolescence.	2013	Alemán-Gómez, Y.; Janssen, J.; Schnack, H.; Balaban, E.; Pina-Camacho, L.; Alfaro-Almagro, F.; Castro-Fornieles, J.; Otero, S.; Baeza, I.; Moreno, D.; Bargalló, N.; Parellada, M.; Arango, C.; Desco, M.	Journal of Neuroscience, 33(38):15004-15010, 2013. (F.I.: 6.908).
Deficits in executive and memory processes in delusional disorder: a case-control study.	2013	Ibanez-Casas, I.; De Portugal, E.; Gonzalez, N.; McKenney, KA.; Haro, JM.; Usall, J.; Perez-Garcia, M.; Cervilla, JA.	Plos One, 8(7):e67341, 2013. (F.I.: 3.730).
Prevalence of premorbid personality disorder and its clinical correlates in patients with delusional disorder.	2013	de Portugal, E.; Díaz-Caneja, CM.; González-Molinier, M.; de Castro, MJ.; Del Amo, V.; Arango, C.; Cervilla, JA.	Psychiatry Research.
Impact of caregiving experience on mental health among caregivers: a comparison of eating disorder patients with purging and non-purging behaviors	2013	Sepulveda, AR.; Anastasiadou, D.; Pellegrin, Y.; Andrés, P.; Graell, M.; Carrobles, JA.; Morandé, G.	Eating and weight disorders.
White matter microstructure correlates of mathematical giftedness and intelligence quotient.	2013	Navas-Sánchez, FJ.; Alemán-Gómez, Y.; Sánchez-Gonzalez, J.; Guzmán-De-Villoria, JA.; Franco, C.; Robles, O.; Arango, C.; Desco, M.	Human Brain Mapping.
The bipolar-depressive continuum in the National Epidemiologic Survey on Alcohol and Related Conditions.	2013	Moreno, C.; Hasin, DS.; Arango, C.; Oquendo, MA.; Vieta, E.; Liu, S.; Grant, BF.; Blanco, C.	Bipolar Disorders, 15(1):112-113, 2013. (F.I.: 4.621).
Paediatric European Risperidone Studies (PERS): context, rationale, objectives, strategy, and challenges.	2013	Glennon, J.; Purper-Ouakil, D.; Bakker, M.; Zuddas, A.; Hoekstra, P.; Schulze, U.; Castro-Fornieles, J.; Santosh, PJ.; Arango, C.; Kölch, M.; Coghill, D.; Flamarique, I.; Penzol, MJ.; Wan, M.; Murray, M.; Wong, ICK.; Danckaerts, M.; Bonnot, O.; Falissard, B.; Masi, G.; Fegert, JM.; Vicari, S.; Carucci, s.; Dittmann, RW.; Buitelaar, JK.; and the PERS Consortium.	European Child and Adolescent Psychiatry. (en prensa). (F.I.: 3.699).
Pharmacological approaches to treating negative symptoms: A review of clinical trials.	2013	Arango, C.; Garibaldi, G.; Marder, SR.	Schizophrenia Research. 2013 Nov;150(2-3):346-52 (F.I.: 4.590).

The Spanish validation of an Eating Disorders Symptom Impact Scale (EDSIS) among caregivers.	2013	Carral-Fernández, L.; Sepulveda, AR.; Gómez Del Barrio, A.; Graell, M.; Treasure, J.	Psychiatry Research, 209(3):626-31, 2013. (F.I.: 2.456).